To offer an in-depth discussion of business while customers will comment on industry trends as well as their experiences using company's solutions to help lower pharmacy benefit costs and grow their business

SXC Health Solutions Corp. reported unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2009. For the quarter, the company reported total revenue of $383.529 million, operating income of $18.989 million, income before income taxes of $18.022 million and net income of $11.209 million or $0.43 per diluted share against total revenue of $318.101 million, operating income of $5.866 million, income before income taxes of $4.815 million and net income of $3.539 million or $0.15 per diluted share for the same period last year. Net cash provided by operating activities was $17.912 million against $3.270 million for the same period last year. Purchases of property and equipment $865,000 against $2.556 million for the same period last year. For the nine months, the company reported total revenue of $995.318 million, operating income of $48.363 million, income before income taxes of $45.749 million and net income of $30.868 million or $1.22 per diluted share against total revenue of $570.173 million, operating income of $13.797 million, income before income taxes of $13.614 million and net income of $10.163 million or $0.44 per diluted share for the same period last year. Net cash provided by operating activities was $49.593 million against $20.599 million for the same period last year. Purchases of property and equipment $6.611 million against $5.970 million for the same period last year. The company revised certain of its 2009 financial targets. Revenue of $1.375-$1.425 billion versus prior estimate of $1.35-$1.4 billion, fully-diluted GAAP EPS (including all transaction-related amortization) of $1.57-$1.62 versus prior estimate of $1.42-$1.50, adjusted EBITDA of $87-$89 million versus prior estimate of $78-$81 million fully-diluted Non-GAAP adjusted earnings per share(1) (excluding the NMHC transaction-related amortization) of $1.76-$1.81 versus prior estimate of $1.62-$1.70.

SXC Health Solutions, Corp. announced that its informed Rx PBM unit has been awarded a four-year contract to provide PBM services to Spectral Solutions LLC.